Sub-$1 Watch: 10 Stocks That Could Explode — July 15, 2026

Introduction

Investing in sub-$1 stocks can be a double-edged sword. While these equities present a high-risk, high-reward scenario, understanding their fundamentals, technical setups, and market catalysts is crucial for potential investors. Below are ten stocks under $1 that exhibit significant speculative potential.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.45 - **Sector**: Cannabis - **Volume Profile**: Increasing volume indicates accumulation. - **Short Interest**: 20% of float; potential for a short squeeze. - **Catalyst**: Possible legalization of cannabis in additional states could boost sales. - **Technical Setup**: Recently bounced off a support level of $0.40. - **Risk Factors**: Regulatory hurdles and market competition. - **Bull Case Price Target**: $0.75 in the next 90 days. - **Risk Rating**: 🟡 High

2. MVIS - MicroVision Inc. - **Current Price**: $0.89 - **Sector**: Technology - **Volume Profile**: Steady increase in volume over the last month. - **Short Interest**: 15% of float; potential for a squeeze. - **Catalyst**: Development of new Lidar technology could attract partnerships. - **Technical Setup**: Breaking out of a multi-month consolidation phase. - **Risk Factors**: Heavy reliance on partnership success and cash burn. - **Bull Case Price Target**: $1.20 in 60 days. - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.78 - **Sector**: Healthcare - **Volume Profile**: Volume has spiked significantly in recent sessions. - **Short Interest**: 25% of float; high potential for short covering. - **Catalyst**: Upcoming quarterly earnings could reveal positive trends. - **Technical Setup**: Forming a bullish reversal pattern. - **Risk Factors**: Market volatility and potential regulatory scrutiny. - **Bull Case Price Target**: $1.10 in 30 days. - **Risk Rating**: 🟡 High

4. ZOM - Zomedica Corp. - **Current Price**: $0.35 - **Sector**: Biotechnology - **Volume Profile**: Increased volume indicates accumulation. - **Short Interest**: 18% of float; short squeeze potential. - **Catalyst**: Upcoming product launch in veterinary medicine. - **Technical Setup**: Testing key support levels. - **Risk Factors**: Product reception and market demand uncertainty. - **Bull Case Price Target**: $0.60 in 90 days. - **Risk Rating**: 🟡 High

5. ACB - Aurora Cannabis Inc. - **Current Price**: $0.58 - **Sector**: Cannabis - **Volume Profile**: Recent surge in trading volume. - **Short Interest**: 22% of float; could trigger a short squeeze. - **Catalyst**: Expansion into new international markets. - **Technical Setup**: Rebounding from a significant support zone. - **Risk Factors**: Ongoing financial losses and competition. - **Bull Case Price Target**: $0.85 in 60 days. - **Risk Rating**: 🟡 High

6. NAKD - Naked Brand Group Ltd. - **Current Price**: $0.40 - **Sector**: Retail - **Volume Profile**: Increasing volume suggests accumulation. - **Short Interest**: 30% of float; very high short interest. - **Catalyst**: New product launches and marketing campaigns. - **Technical Setup**: Currently consolidating after a prior rally. - **Risk Factors**: Consumer trends and brand perception. - **Bull Case Price Target**: $0.65 in 90 days. - **Risk Rating**: 🟡 High

7. XELA - Exela Technologies Inc. - **Current Price**: $0.25 - **Sector**: Technology - **Volume Profile**: Volume has been steadily increasing. - **Short Interest**: 19% of float; potential squeeze. - **Catalyst**: Partnerships in the digital transformation space. - **Technical Setup**: Forming a bullish divergence. - **Risk Factors**: Debt levels and operational challenges. - **Bull Case Price Target**: $0.50 in 60 days. - **Risk Rating**: 🟡 High

8. JAGX - Jagreen Inc. - **Current Price**: $0.68 - **Sector**: Biotechnology - **Volume Profile**: Significant increase in trading volume. - **Short Interest**: 21% of float; high potential for a short squeeze. - **Catalyst**: FDA approval for their lead drug candidate. - **Technical Setup**: Recent bounce off support. - **Risk Factors**: Regulatory delays and clinical trial failures. - **Bull Case Price Target**: $1.00 in 90 days. - **Risk Rating**: 🟡 High

9. GTE - Gran Tierra Energy Inc. - **Current Price**: $0.55 - **Sector**: Energy - **Volume Profile**: Increasing volume indicates accumulation. - **Short Interest**: 17% of float; potential for a squeeze. - **Catalyst**: Rising oil prices and operational efficiency improvements. - **Technical Setup**: Testing key resistance levels. - **Risk Factors**: Oil price volatility and geopolitical risks. - **Bull Case Price Target**: $0.80 in 60 days. - **Risk Rating**: 🟡 High

10. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.02 - **Sector**: Consumer Goods - **Volume Profile**: Surge in volume suggests potential accumulation. - **Short Interest**: 15% of float; moderate potential for squeeze. - **Catalyst**: Ongoing litigation and product developments. - **Technical Setup**: Stabilizing after a prolonged downtrend. - **Risk Factors**: Legal outcomes and product acceptance. - **Bull Case Price Target**: $0.04 in 90 days. - **Risk Rating**: 🟡 High

Why These Price Ranges Matter

Low-float, low-price stocks often present mechanical advantages, including higher volatility, which can lead to rapid price movements based on small changes in demand. The potential for gains is substantial, but so are the risks, making them attractive for speculative traders.

How to Trade Them Safely

Position sizing is critical when trading low-priced stocks. Use limit orders to control entry points, and always consider catalyst timing to capitalize on potential price movements. Risk management strategies, such as setting stop-loss orders, are essential in mitigating downside risk.

Catalyst Calendar

• SNDL: Q2 earnings release on August 10, 2026.
• CLOV: Earnings report scheduled for August 15, 2026.
• JAGX: FDA decision expected by September 2026.

Investing in these stocks requires careful consideration and risk management. The speculative nature of these equities can lead to significant volatility, so thorough due diligence is essential.

Educational content only. Not financial advice. DYOR.